关注
Avik Ray
Avik Ray
Postdoctoral Research Fellow, Harvard Medical School and Brigham & Women's Hospital
在 bwh.harvard.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results
WHO Solidarity Trial Consortium
New England journal of medicine 384 (6), 497-511, 2021
27492021
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ...
The Lancet 399 (10339), 1941-1953, 2022
2732022
Metformin in COVID-19: A possible role beyond diabetes
S Sharma, A Ray, B Sadasivam
Diabetes Research and Clinical Practice 164, 108183, 2020
2132020
A cost variation analysis of drugs available in the Indian market for the management of thromboembolic disorders
A Ray, A Najmi, G Khandelwal, B Sadasivam
Cureus 12 (5), 2020
322020
The potential therapeutic role of proton pump inhibitors in COVID-19: hypotheses based on existing evidences
A Ray, S Sharma, B Sadasivam
Drug Research 70 (10), 484-488, 2020
262020
Medication concordance in modern medicine–A critical appraisal from an Indian perspective
S Atal, B Sadasivam, SN Ahmed, A Ray
Journal of Family Medicine and Primary Care 8 (4), 1313, 2019
212019
Famotidine repurposing for novel corona virus disease of 2019: a systematic review
S Chenchula, A Ray, B Sadasivam
Drug Research 71 (06), 295-301, 2021
192021
How to choose and interpret a statistical test? An update for budding researchers
A Najmi, B Sadasivam, A Ray
Journal of family medicine and primary care 10 (8), 2763-2767, 2021
182021
A multicentre point prevalence survey (PPS) of antimicrobial use amongst admitted patients in tertiary care centres in India
AM Panditrao, N Shafiq, S Chatterjee, A Pathak, N Trivedi, B Sadasivam, ...
Journal of Antimicrobial Chemotherapy 76 (4), 1094-1101, 2021
132021
Carbovigilance: curtailing the global pharmaceutical carbon footprint
A Ray, S Sharma, B Sadasivam
Future Healthcare Journal 8 (3), e683-e685, 2021
112021
Understanding the molecular–pharmaceutical basis of sartan recalls focusing on valsartan
A Ray, S Atal, B Sadasivam
Global cardiology science & practice 2020 (2), 2020
92020
Risperidone-induced somnambulism: a case report and brief review of literature
A Najmi, F Siddiqui, A Ray, R Jhaj, B Sadasivam
Cureus 12 (3), 2020
82020
Tigecycline-induced severe hypoglycemia in a Non-Diabetic individual: a case report and brief review of tigecycline-induced severe hypoglycemia
A Ray, S Sharma, S Atal, B Sadasivam, R Jhaj
The American Journal of Case Reports 21, e924556-1, 2020
82020
COVID-19 and thrombotic complications—the role of anticoagulants, antiplatelets and thrombolytics
G Khandelwal, A Ray, S Sethi, HK Harikrishnan, C Khandelwal, ...
Journal of Family Medicine and Primary Care 10 (10), 3561-3567, 2021
72021
Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized trials
A Ray, A Najmi, G Khandelwal, R Jhaj, B Sadasivam
Cardiovascular Drugs and Therapy 35, 561-574, 2021
72021
Use of handheld infrared thermometers in COVID-19 pandemic for mass screening: Understanding its implications through a case report
A Najmi, S Kaore, A Ray, B Sadasivam
Journal of Family Medicine and Primary Care 9 (10), 5421-5422, 2020
72020
Adaptations in teaching modalities for medical undergraduates in response to coronavirus disease 2019 at a single teaching institute in India
S Sharma, A Ray, B Sadasivam
Korean Journal of Medical Education 32 (4), 291, 2020
62020
Medication adherence, recall periods and factors affecting it: a community‐based assessment on patients with chronic diseases in urban slums
S Atal, A Ray, SN Ahmed, P Singh, Z Fatima, B Sadasivam, A Pakhare, ...
International Journal of Clinical Practice 75 (8), e14316, 2021
52021
Organoids: An invaluable tool in pharmacology
S Balakrishnan, S Atal, A Ray, CA Pravin, M Nanda
Indian Journal of Pharmacology 52 (5), 422-429, 2020
52020
Review of antiviral activities present in some Indian medicinal plants–Can they be used against SARS-CoV-2
A Najmi, D Javed, A Ray, B Sadasivam
Int Arch BioMed Clin Res 6 (4), RA1-RA5, 2020
42020
系统目前无法执行此操作,请稍后再试。
文章 1–20